Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.12 - $1.57 $12,275 - $17,207
-10,960 Reduced 38.91%
17,207 $25,000
Q4 2023

Feb 13, 2024

SELL
$0.72 - $1.56 $6,906 - $14,965
-9,593 Reduced 25.41%
28,167 $40,000
Q3 2023

Nov 14, 2023

SELL
$1.07 - $1.39 $20,507 - $26,640
-19,166 Reduced 33.67%
37,760 $40,000
Q2 2023

Aug 21, 2023

SELL
$1.12 - $1.82 $8,103 - $13,167
-7,235 Reduced 11.28%
56,926 $73,000
Q1 2023

May 09, 2023

SELL
$1.25 - $2.0 $9,517 - $15,228
-7,614 Reduced 10.61%
64,161 $84,000
Q4 2022

Feb 14, 2023

SELL
$0.67 - $11.9 $96,747 - $1.72 Million
-144,399 Reduced 66.8%
71,775 $107,000
Q3 2022

Nov 18, 2022

SELL
$1.1 - $12.2 $5,706 - $63,293
-5,188 Reduced 2.34%
216,174 $255,000
Q2 2022

Aug 15, 2022

SELL
$0.67 - $3.19 $2,047 - $9,748
-3,056 Reduced 1.36%
221,362 $250,000
Q1 2022

May 16, 2022

SELL
$2.22 - $3.45 $29,323 - $45,571
-13,209 Reduced 5.56%
224,418 $671,000
Q4 2021

Feb 15, 2022

BUY
$2.36 - $3.57 $15,420 - $23,326
6,534 Added 2.83%
237,627 $630,000
Q3 2021

Nov 15, 2021

SELL
$3.5 - $4.5 $16,131 - $20,740
-4,609 Reduced 1.96%
231,093 $839,000
Q2 2021

Aug 16, 2021

SELL
$3.09 - $4.54 $63,434 - $93,201
-20,529 Reduced 8.01%
235,702 $1.02 Million
Q1 2021

May 18, 2021

SELL
$3.35 - $4.93 $5,701 - $8,390
-1,702 Reduced 0.66%
256,231 $876,000
Q4 2020

Feb 16, 2021

BUY
$2.35 - $3.74 $6,283 - $10,000
2,674 Added 1.05%
257,933 $903,000
Q3 2020

Nov 17, 2020

BUY
$1.78 - $4.13 $2,127 - $4,935
1,195 Added 0.47%
255,259 $613,000
Q1 2020

May 13, 2020

SELL
$1.27 - $3.0 $10,232 - $24,171
-8,057 Reduced 3.07%
254,064 $396,000
Q3 2019

Nov 15, 2019

BUY
$1.63 - $2.62 $8,244 - $13,251
5,058 Added 1.97%
262,121 $490,000
Q1 2019

May 09, 2019

SELL
$2.0 - $2.65 $11,796 - $15,629
-5,898 Reduced 2.24%
257,063 $661,000
Q4 2018

Feb 13, 2019

BUY
$2.08 - $3.36 $18,179 - $29,366
8,740 Added 3.44%
262,961 $605,000
Q3 2018

Nov 14, 2018

BUY
$2.6 - $3.59 $4,414 - $6,095
1,698 Added 0.67%
254,221 $816,000
Q2 2018

Aug 14, 2018

BUY
$2.83 - $4.11 $78,696 - $114,290
27,808 Added 12.37%
252,523 $715,000
Q1 2018

May 15, 2018

SELL
$3.54 - $4.54 $29,944 - $38,403
-8,459 Reduced 3.63%
224,715 $795,000
Q4 2017

Feb 14, 2018

BUY
$3.23 - $4.3 $108,227 - $144,080
33,507 Added 16.78%
233,174 $905,000
Q3 2017

Nov 13, 2017

BUY
$2.18 - $2.57 $435,274 - $513,144
199,667
199,667 $507,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.84B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.